Superstring Capital Management LP Bridge Bio Pharma, Inc. Transaction History
Superstring Capital Management LP
- $84 Billion
- Q1 2025
A detailed history of Superstring Capital Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 183,922 shares of BBIO stock, worth $9.05 Million. This represents 7.56% of its overall portfolio holdings.
Number of Shares
183,922
Previous 262,141
29.84%
Holding current value
$9.05 Million
Previous $7.19 Billion
11.61%
% of portfolio
7.56%
Previous 6.23%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
376Shares Held
184MCall Options Held
12.8MPut Options Held
2.28M-
Viking Global Investors LP22.1MShares$1.09 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$948 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$733 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$613 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$353 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.3B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...